BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

849 related articles for article (PubMed ID: 24876351)

  • 1. Chemokine (C-X-C motif) receptor 4 blockade by AMD3100 inhibits experimental abdominal aortic aneurysm expansion through anti-inflammatory effects.
    Michineau S; Franck G; Wagner-Ballon O; Dai J; Allaire E; Gervais M
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1747-55. PubMed ID: 24876351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression.
    Iida Y; Xu B; Xuan H; Glover KJ; Tanaka H; Hu X; Fujimura N; Wang W; Schultz JR; Turner CR; Dalman RL
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):718-26. PubMed ID: 23288157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Ablation of MicroRNA-33 Attenuates Inflammation and Abdominal Aortic Aneurysm Formation via Several Anti-Inflammatory Pathways.
    Nakao T; Horie T; Baba O; Nishiga M; Nishino T; Izuhara M; Kuwabara Y; Nishi H; Usami S; Nakazeki F; Ide Y; Koyama S; Kimura M; Sowa N; Ohno S; Aoki H; Hasegawa K; Sakamoto K; Minatoya K; Kimura T; Ono K
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2161-2170. PubMed ID: 28882868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization.
    Kaneko H; Anzai T; Morisawa M; Kohno T; Nagai T; Anzai A; Takahashi T; Shimoda M; Sasaki A; Maekawa Y; Yoshimura K; Aoki H; Tsubota K; Yoshikawa T; Okada Y; Ogawa S; Fukuda K
    Atherosclerosis; 2011 Aug; 217(2):350-7. PubMed ID: 21530968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane-Bound Thrombomodulin Regulates Macrophage Inflammation in Abdominal Aortic Aneurysm.
    Wang KC; Li YH; Shi GY; Tsai HW; Luo CY; Cheng MH; Ma CY; Hsu YY; Cheng TL; Chang BI; Lai CH; Wu HL
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2412-22. PubMed ID: 26338301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage-derived angiopoietin-like protein 2 accelerates development of abdominal aortic aneurysm.
    Tazume H; Miyata K; Tian Z; Endo M; Horiguchi H; Takahashi O; Horio E; Tsukano H; Kadomatsu T; Nakashima Y; Kunitomo R; Kaneko Y; Moriyama S; Sakaguchi H; Okamoto K; Hara M; Yoshinaga T; Yoshimura K; Aoki H; Araki K; Hao H; Kawasuji M; Oike Y
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1400-9. PubMed ID: 22556334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine (C-C motif) receptor 2 mediates mast cell migration to abdominal aortic aneurysm lesions in mice.
    Zhang J; Chen H; Liu L; Sun J; Shi MA; Sukhova GK; Shi GP
    Cardiovasc Res; 2012 Dec; 96(3):543-51. PubMed ID: 22871590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergic Lung Inflammation Aggravates Angiotensin II-Induced Abdominal Aortic Aneurysms in Mice.
    Liu CL; Wang Y; Liao M; Wemmelund H; Ren J; Fernandes C; Zhou Y; Sukhova GK; Lindholt JS; Johnsen SP; Zhang JY; Cheng X; Huang X; Daugherty A; Levy BD; Libby P; Shi GP
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):69-77. PubMed ID: 26543094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor Xa inhibitor rivaroxaban suppresses experimental abdominal aortic aneurysm progression via attenuating aortic inflammation.
    Ding Y; Li X; Zhou M; Cai L; Tang H; Xie T; Shi Z; Fu W
    Vascul Pharmacol; 2021 Feb; 136():106818. PubMed ID: 33227452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammation.
    Leeper NJ; Tedesco MM; Kojima Y; Schultz GM; Kundu RK; Ashley EA; Tsao PS; Dalman RL; Quertermous T
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1329-35. PubMed ID: 19304942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammasome activation by mitochondrial oxidative stress in macrophages leads to the development of angiotensin II-induced aortic aneurysm.
    Usui F; Shirasuna K; Kimura H; Tatsumi K; Kawashima A; Karasawa T; Yoshimura K; Aoki H; Tsutsui H; Noda T; Sagara J; Taniguchi S; Takahashi M
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):127-36. PubMed ID: 25378412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD95-ligand contributes to abdominal aortic aneurysm progression by modulating inflammation.
    Liu Z; Fitzgerald M; Meisinger T; Batra R; Suh M; Greene H; Penrice AJ; Sun L; Baxter BT; Xiong W
    Cardiovasc Res; 2019 Mar; 115(4):807-818. PubMed ID: 30428004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spermidine Suppresses Development of Experimental Abdominal Aortic Aneurysms.
    Liu S; Huang T; Liu R; Cai H; Pan B; Liao M; Yang P; Wang L; Huang J; Ge Y; Xu B; Wang W
    J Am Heart Assoc; 2020 Apr; 9(8):e014757. PubMed ID: 32308093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolvin D1 decreases abdominal aortic aneurysm formation by inhibiting NETosis in a mouse model.
    Spinosa M; Su G; Salmon MD; Lu G; Cullen JM; Fashandi AZ; Hawkins RB; Montgomery W; Meher AK; Conte MS; Sharma AK; Ailawadi G; Upchurch GR
    J Vasc Surg; 2018 Dec; 68(6S):93S-103S. PubMed ID: 30470363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of CaCl
    Ishida Y; Kuninaka Y; Nosaka M; Kimura A; Taruya A; Furuta M; Mukaida N; Kondo T
    Nat Commun; 2020 Nov; 11(1):5994. PubMed ID: 33239616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of catalase in vascular smooth muscle cells prevents the formation of abdominal aortic aneurysms.
    Parastatidis I; Weiss D; Joseph G; Taylor WR
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2389-96. PubMed ID: 23950141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow mesenchymal stem cells stabilize already-formed aortic aneurysms more efficiently than vascular smooth muscle cells in a rat model.
    Schneider F; Saucy F; de Blic R; Dai J; Mohand F; Rouard H; Ricco JB; Becquemin JP; Gervais M; Allaire E
    Eur J Vasc Endovasc Surg; 2013 Jun; 45(6):666-72. PubMed ID: 23598054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of abdominal aortic aneurysm formation by inhibition of prolyl hydroxylase domain protein through attenuation of inflammation and extracellular matrix disruption.
    Watanabe A; Ichiki T; Sankoda C; Takahara Y; Ikeda J; Inoue E; Tokunou T; Kitamoto S; Sunagawa K
    Clin Sci (Lond); 2014 May; 126(9):671-8. PubMed ID: 24256203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Interleukin-1 Signaling in a Mouse Model of Kawasaki Disease-Associated Abdominal Aortic Aneurysm.
    Wakita D; Kurashima Y; Crother TR; Noval Rivas M; Lee Y; Chen S; Fury W; Bai Y; Wagner S; Li D; Lehman T; Fishbein MC; Hoffman HM; Shah PK; Shimada K; Arditi M
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):886-97. PubMed ID: 26941015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of vascular endothelial growth factor-A in development of abdominal aortic aneurysm.
    Kaneko H; Anzai T; Takahashi T; Kohno T; Shimoda M; Sasaki A; Shimizu H; Nagai T; Maekawa Y; Yoshimura K; Aoki H; Yoshikawa T; Okada Y; Yozu R; Ogawa S; Fukuda K
    Cardiovasc Res; 2011 Jul; 91(2):358-67. PubMed ID: 21436157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.